Page last updated: 2024-08-17

quinoxalines and Brain Embolism and Thrombosis

quinoxalines has been researched along with Brain Embolism and Thrombosis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boysen, G; Overgaard, K; Pedersen, H; Sereghy, T1
Boysen, G; Meden, P; Overgaard, K; Sereghy, T1
Cai, H; Fujishima, M; Ibayashi, S; Nakane, H; Uchimura, H; Yao, H1
Umemura, K1
Ikeda, Y; Kondo, K; Takamatsu, H; Umemura, K1

Reviews

1 review(s) available for quinoxalines and Brain Embolism and Thrombosis

ArticleYear
[A novel photochemical model of the middle cerebral artery for thrombosis research and evaluation of anti-thrombotic agents].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1997, Volume: 109, Issue:4

    Topics: Animals; Disease Models, Animal; Drug Evaluation; Fibrinolytic Agents; Fluorescent Dyes; Glutamic Acid; Intracranial Embolism and Thrombosis; Light; Magnetic Resonance Imaging; Nicotinic Acids; Photochemistry; Quinoxalines; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Rose Bengal

1997

Other Studies

4 other study(ies) available for quinoxalines and Brain Embolism and Thrombosis

ArticleYear
Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke.
    Neurological research, 1993, Volume: 15, Issue:5

    Topics: Animals; Brain Edema; Cerebral Infarction; Cerebrovascular Circulation; Fibrinolysis; Intracranial Embolism and Thrombosis; Male; Paralysis; Quinoxalines; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator; Weight Loss

1993
Enhancing the efficacy of thrombolysis by AMPA receptor blockade with NBQX in a rat embolic stroke model.
    Journal of the neurological sciences, 1993, Volume: 119, Issue:2

    Topics: Animals; Blood Pressure; Cerebral Angiography; Cerebral Infarction; Cerebrovascular Circulation; Cerebrovascular Disorders; Fibrinolytic Agents; Intracranial Embolism and Thrombosis; Male; Plasminogen Activators; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA

1993
AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats.
    Brain research, 1997, Apr-04, Volume: 753, Issue:1

    Topics: Animals; Arterial Occlusive Diseases; Cerebral Infarction; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Hypertension; Intracranial Embolism and Thrombosis; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Inbred SHR; Receptors, AMPA

1997
Neuroprotective effects depend on the model of focal ischemia following middle cerebral artery occlusion.
    European journal of pharmacology, 1998, Dec-04, Volume: 362, Issue:2-3

    Topics: Animals; Brain Edema; Brain Ischemia; Disease Models, Animal; Dizocilpine Maleate; Electrocoagulation; Immunosuppressive Agents; Injections, Intraperitoneal; Injections, Intravenous; Intracranial Embolism and Thrombosis; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Tacrolimus

1998